Plaintiff alleges that on October 28, 2025, defendants released third quarter results below prior projections and lowered their full-year guidance. On this news, the price of Varonis' common stock declined from $63.00 per share on October 28, 2025, to $32.34 per share on October 29, 2025, a decline of about 48.67% in the span of just a single day. SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Varonis ...

NEW YORK--(BUSINESS WIRE)---- $FRMI #AI--Fermi Inc. Announces Cancellation of $150 million Customer Agreement Triggering Securities Class Action after Stock Drops Over 33% - Contact BFA Law. ...

New York, New York--(Newsfile Corp. - January 5, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed.If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.Why are Jefferies ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Alexandria Real Estate Equities securities between January 27, 2025, and October 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 26, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [7]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Background - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its real estate operations [5]. - Defendants reportedly made positive statements about Alexandria Real Estate's lease activity and occupancy stability while concealing adverse facts about the true state of its Long Island City property [6].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Agilon Health, Inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025, alleging that the company misled investors regarding its business prospects [1] Allegations - The complaint asserts that Agilon Health, Inc. failed to disclose that it issued guidance for 2025 that was unrealistic, given the material industry challenges they were aware of, and that they materially overstated the financial benefits from strategic actions taken to mitigate risks [2] Company Developments - On August 4, 2025, Agilon announced the resignation of Steven Sell as President, CEO, and Director, stating that his departure was a termination without 'cause' according to his employment agreement. The same day, the company released disappointing financial results, leading to a stock price drop of over 50%, closing at $0.8801 on August 5, 2025 [3] Class Action Participation - Shareholders may be eligible to participate in the class action against Agilon Health, Inc. Those interested in serving as lead plaintiffs should contact Robbins LLP. Participation is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Blue Owl Capital Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The Class Period for the Blue Owl securities is from February 6, 2025, to November 16, 2025 [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 2, 2026 [2] Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [3] - Rosen Law Firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company [3] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions for investors [3] Group 3: Case Allegations - The lawsuit alleges that Blue Owl made false or misleading statements regarding its asset base and liquidity issues due to BDC redemptions [4] - It is claimed that Blue Owl was likely to limit or halt redemptions of certain BDCs, which was not disclosed to investors [4] - The misleading statements about Blue Owl's business operations led to investor damages when the true situation was revealed [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SLM Corporation securities between July 25, 2025, and August 14, 2025, of the February 17, 2026, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought SLM securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by February 17, 2026, to serve as lead plaintiffs [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that SLM Corporation made false and misleading statements regarding its financial stability, particularly concerning early-stage delinquencies and the effectiveness of its loss mitigation programs [5]. - It is claimed that these misrepresentations led to a materially false impression of SLM's business operations and prospects, resulting in investor damages when the truth was revealed [5].

Core Viewpoint - A class action has been filed against Integer Holdings Corporation (ITGR) for allegedly misleading investors about the demand for its electrophysiology (EP) devices, which has reportedly declined significantly [1][2]. Group 1: Allegations and Market Position - The complaint claims that Integer Holdings misrepresented its market position in the growing EP market and overstated the demand for its EP devices, which has actually decreased [2]. - Contrary to expectations, revenue growth from Integer's EP devices is decelerating rather than outpacing market growth [2]. Group 2: Financial Guidance and Stock Impact - On October 23, 2025, Integer revised its full-year 2025 guidance, projecting net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026 [3]. - The company acknowledged that two of its EP devices had slower than anticipated market adoption, with expectations of continued slow demand into 2026 [3]. - Following this announcement, Integer's stock price dropped by $35.22, or over 32%, closing at $73.89 per share [3]. Group 3: Class Action Participation - Shareholders may be eligible to participate in the class action against Integer Holdings, with a deadline of February 9, 2026, for those wishing to serve as lead plaintiff [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Group 4: Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Integer Holdings Corporation common stock of the upcoming lead plaintiff deadline for a class action lawsuit related to alleged misleading statements made by the company during the specified class period [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from July 25, 2024, to October 22, 2025, inclusive [1]. - Investors who purchased Integer common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by February 9, 2026 [3]. Group 2: Allegations Against Integer Holdings - The lawsuit alleges that Integer made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market [5]. - It is claimed that Integer overstated its visibility into customer demand while experiencing a deterioration in sales for two of its electrophysiology devices [5]. - The company mischaracterized its electrophysiology devices as long-term growth drivers for its cardio and vascular segment, leading to misleading positive statements about its business and operations [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Inspire Medical common stock between August 6, 2024, and August 4, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 5, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Specifics - The lawsuit alleges that Inspire Medical misrepresented key facts about its sleep apnea device, Inspire V, including market demand and necessary steps for its launch, leading to misleading statements that caused investor losses when the truth was revealed [5].